Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Jul 2026 07:00 AM
RNS
Portfolio Update and Presentation
01 Jul 2026 07:00 AM
RNS
Portfolio Update: Glycotest and ProAxsis
17 Jun 2026 02:32 PM
RNS
Result of AGM
22 May 2026 12:38 PM
RNS
Posting of Annual Report and Notice of AGM
21 May 2026 07:00 AM
RNS
AMR Bio: Commercial Update
19 May 2026 07:01 AM
RNS
Final Results for the year ended 31 December 2025
19 May 2026 07:00 AM
RNS
Phantom Carried Interest Scheme
14 May 2026 07:00 AM
RNS
Notice of Final Results
24 Feb 2026 12:38 PM
RNS
TR-1
12 Feb 2026 07:00 AM
RNS
Portfolio Update
02 Feb 2026 07:00 AM
RNS
Trading and Portfolio Update
08 Jan 2026 07:00 AM
RNS
PDMR Dealing
23 Dec 2025 07:00 AM
RNS
Sofant Technologies: Fundraising
19 Dec 2025 07:00 AM
RNS
Director/PDMR Dealing
10 Dec 2025 07:00 AM
RNS
Wanda Health: Fundraising and Business Update
08 Dec 2025 07:00 AM
RNS
Share Issue, PDMR Dealings & Total Voting Rights
04 Dec 2025 07:00 AM
RNS
TR-1
24 Nov 2025 07:00 AM
RNS
Expansion of Senior Finance Leadership Team
20 Nov 2025 07:00 AM
RNS
Portfolio Update
30 Sep 2025 07:00 AM
RNS
Interim Results and Investor Presentation
22 Sep 2025 07:00 AM
RNS
Asset Purchase Agreement with Destiny Pharma
18 Sep 2025 07:00 AM
RNS
Notice of Interim Results
30 Jun 2025 12:22 PM
RNS
Result of AGM
30 Jun 2025 07:00 AM
RNS
Office move and Related Party Transaction
27 Jun 2025 07:00 AM
RNS
Q-Bot Limited Fundraising
10 Jun 2025 01:28 PM
RNS
TR-1
06 Jun 2025 03:12 PM
RNS
Notice of AGM and Annual Report & Accounts
04 Jun 2025 02:34 PM
RNS
Director/PDMR Shareholding
04 Jun 2025 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2024
14 May 2025 04:02 PM
RNS
PDS: Q1 Results and Clinical and Corporate Update
09 May 2025 10:30 AM
RNS
TR-1
27 Mar 2025 04:46 PM
RNS
PDS: Q4 Results and Clinical Programs Update
07 Mar 2025 04:26 PM
RNS
PDS: VERSATILE-003 Phase 3 Clinical Trial
27 Feb 2025 04:30 PM
RNS
PDS: up to $22mn Registered Direct Offering
05 Feb 2025 03:24 PM
RNS
PDS Biotech reaffirms guidance for clinical trial
03 Feb 2025 07:00 AM
RNS
ProAxsis: Status Update and Proposed Fundraise
06 Jan 2025 04:42 PM
RNS
TR-1
31 Dec 2024 07:05 AM
RNS
Grant of Share Options
31 Dec 2024 07:00 AM
RNS
Q-Bot Fundraising
12 Dec 2024 04:49 PM
RNS
TR-1
09 Dec 2024 07:00 AM
RNS
Wanda Health Fundraising
05 Dec 2024 07:00 AM
RNS
Close of Fundraising and Result of Retail Offer
03 Dec 2024 01:24 PM
RNS
Result of Subscription
03 Dec 2024 07:05 AM
RNS
WRAP Retail Offer
03 Dec 2024 07:00 AM
RNS
Proposed Subscription and Retail Offer; Update
14 Nov 2024 03:59 PM
RNS
Replacement RNS: PDS: Update, 3rd Quarter Results
14 Nov 2024 03:23 PM
RNS
PDS: Clinical Programs Update, 3rd Quarter Results
08 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
03 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
02 Oct 2024 04:38 PM
RNS
PDS: 36-Month Overall Survival Rate announcement

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100